Previously, we revealed that ROS induced HER2 and HER3 expression in ovarian cancer cells [23]; here, we found that NOX4 knockdown decreased the expression level of HER3, suggesting that NOX4 regulated drug resistance through HER3. This evidence concerns the gene ERBB2 and ovarian cancer.